Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationBone MarrowBone Marrow TransplantationTransplantation, AutologousGraft vs Host DiseaseBone Marrow CellsTransplantation ConditioningStem CellsHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationTransplantation ChimeraTissue DonorsHematopoiesisTreatment OutcomeWhole-Body IrradiationGraft SurvivalCord Blood Stem Cell TransplantationBone and BonesHistocompatibility TestingBusulfanAntigens, CD34Hematopoietic Stem Cell MobilizationHistocompatibilityMyeloablative AgonistsLeukemiaCell DifferentiationRetrospective StudiesChimerismGraft vs Leukemia EffectRecurrenceLiver TransplantationMultiple MyelomaMesenchymal Stem Cell TransplantationMice, Inbred C57BLHematologic DiseasesRemission InductionCell LineageLeukemia, Myeloid, AcuteCombined Modality TherapyFlow CytometryImmunosuppressive AgentsMyelodysplastic SyndromesTime FactorsColony-Forming Units AssayHepatic Veno-Occlusive DiseaseHLA AntigensCell TransplantationStem Cell NicheBone Marrow DiseasesSiblingsVidarabineSurvival RateUnrelated DonorsAnemia, AplasticDisease-Free SurvivalGraft vs Tumor EffectSurvival AnalysisTransplantation ImmunologyCyclophosphamideAdult Stem CellsMelphalanSevere Combined ImmunodeficiencyEmbryonic Stem CellsCells, CulturedGranulocyte Colony-Stimulating FactorLymphocyte TransfusionTransplantation, IsogeneicPrecursor Cell Lymphoblastic Leukemia-LymphomaFetal BloodKidney TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCell SeparationT-LymphocytesBone Marrow ExaminationMesenchymal Stromal CellsCytomegalovirus InfectionsSalvage TherapyLymphocyte DepletionAcute DiseaseAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesAntilymphocyte SerumBone Marrow PurgingCell ProliferationGraft RejectionStem Cell FactorLymphoma, Non-HodgkinDonor SelectionAllograftsImmunosuppressionLeukemia, MyeloidBone RemodelingMultipotent Stem CellsOpportunistic InfectionsBone Marrow NeoplasmsLymphoproliferative DisordersPrognosis